Organisation Of Pharmaceutical Producers Of I

Rediff.com » News » Organisation Of Pharmaceutical Producers Of I

News for Organisation Of Pharmaceutical Producers Of I

News
Business

Govt cuts customs duty on 3 cancer drugs

The government on Tuesday proposed to fully exempt three cancer medicines from customs duties. The government proposes to cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab......

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

Uzbekistan cough syrup deaths: Noida firm loses production licence

The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the results of its controversial cough......

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

The World Health Organisation drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical......

Budget 2024: Wishlist of the pharma industry

There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical......

GST waiver for rare disease drugs brings little relief: pharma sector

India’s pharma sector on Wednesday said the Goods and Services Tax (GST) Council’s decision to exempt tax on rare diseases drugs is unlikely to benefit the population unless the waiver......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

'PVR-INOX Merger In Final Stages'

Photograph: Kind courtesy PVR The National Company Law Tribunal on Thursday, January 12, 2023, approved the merger of multiplex operators PVR and Inox, the two chains said in separate filings to......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

Rediff News

Organisation Of Pharmaceutical Producers Of I

News for Organisation Of Pharmaceutical Producers Of I

Govt cuts customs duty on 3 cancer drugs

AstraZeneca's COVID-19 Vaccine: The TTS Factor

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

Uzbekistan cough syrup deaths: Noida firm loses production licence

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

Budget 2024: Wishlist of the pharma industry

GST waiver for rare disease drugs brings little relief: pharma sector

Budget 2023: What the pharma, healthcare industry seek

'PVR-INOX Merger In Final Stages'

Key mantra for India's pharma sector in 2023

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS